Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q411325> ?p ?o }
Showing triples 1 to 76 of
76
with 100 triples per page.
- Q411325 subject Q5920511.
- Q411325 subject Q6403537.
- Q411325 subject Q7310239.
- Q411325 subject Q8298527.
- Q411325 subject Q8965786.
- Q411325 abstract "Atenolol is a selective β1 receptor antagonist, a drug belonging to the group of beta blockers (sometimes written β-blockers), a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. It works by slowing down the heart and reducing its workload. Unlike propranolol, atenolol does not pass through the blood–brain barrier to a large extent thus decreasing the incidence of various central nervous system side effects.Atenolol is one of the most widely used β-blockers in the United Kingdom and was once the first-line treatment for hypertension. The role for β-blockers in hypertension was downgraded in June 2006 in the United Kingdom to fourth-line, as they perform less appropriately or effectively than newer drugs, particularly in the elderly.".
- Q411325 atcPrefix "C07".
- Q411325 atcSuffix "AB03".
- Q411325 bioavailability "40.0".
- Q411325 casNumber "29122-68-7".
- Q411325 chEBI "2904".
- Q411325 drugbank "DB00335".
- Q411325 fdaUniiCode "50VV3VW0TI".
- Q411325 iupacName "(RS)-2-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide".
- Q411325 pubchem "2249".
- Q411325 thumbnail Atenolol.svg?width=300.
- Q411325 wikiPageExternalLink Beta-blockers-increase-diabetes-risk-50-cent.html.
- Q411325 wikiPageWikiLink Q12152.
- Q411325 wikiPageWikiLink Q12202.
- Q411325 wikiPageWikiLink Q133823.
- Q411325 wikiPageWikiLink Q14821391.
- Q411325 wikiPageWikiLink Q14916359.
- Q411325 wikiPageWikiLink Q1598909.
- Q411325 wikiPageWikiLink Q178061.
- Q411325 wikiPageWikiLink Q180762.
- Q411325 wikiPageWikiLink Q181754.
- Q411325 wikiPageWikiLink Q189961.
- Q411325 wikiPageWikiLink Q190878.
- Q411325 wikiPageWikiLink Q192197.
- Q411325 wikiPageWikiLink Q200656.
- Q411325 wikiPageWikiLink Q202758.
- Q411325 wikiPageWikiLink Q217111.
- Q411325 wikiPageWikiLink Q26272.
- Q411325 wikiPageWikiLink Q275419.
- Q411325 wikiPageWikiLink Q2914873.
- Q411325 wikiPageWikiLink Q3025883.
- Q411325 wikiPageWikiLink Q3505252.
- Q411325 wikiPageWikiLink Q389735.
- Q411325 wikiPageWikiLink Q410358.
- Q411325 wikiPageWikiLink Q410943.
- Q411325 wikiPageWikiLink Q4134964.
- Q411325 wikiPageWikiLink Q41861.
- Q411325 wikiPageWikiLink Q422782.
- Q411325 wikiPageWikiLink Q423364.
- Q411325 wikiPageWikiLink Q467717.
- Q411325 wikiPageWikiLink Q47273.
- Q411325 wikiPageWikiLink Q56002.
- Q411325 wikiPageWikiLink Q5920511.
- Q411325 wikiPageWikiLink Q6403537.
- Q411325 wikiPageWikiLink Q640448.
- Q411325 wikiPageWikiLink Q653924.
- Q411325 wikiPageWikiLink Q7310239.
- Q411325 wikiPageWikiLink Q816759.
- Q411325 wikiPageWikiLink Q8298527.
- Q411325 wikiPageWikiLink Q8386.
- Q411325 wikiPageWikiLink Q8965786.
- Q411325 wikiPageWikiLink Q9368.
- Q411325 wikiPageWikiLink Q9377.
- Q411325 atcPrefix "7.0".
- Q411325 atcSuffix "AB03".
- Q411325 bioavailability "40".
- Q411325 casNumber "29122".
- Q411325 chebi "2904".
- Q411325 drugbank "DB00335".
- Q411325 iupacName "-2".
- Q411325 pubchem "2249".
- Q411325 unii "50".
- Q411325 type ChemicalSubstance.
- Q411325 type Drug.
- Q411325 type ChemicalObject.
- Q411325 type Thing.
- Q411325 type Q8386.
- Q411325 comment "Atenolol is a selective β1 receptor antagonist, a drug belonging to the group of beta blockers (sometimes written β-blockers), a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. It works by slowing down the heart and reducing its workload.".
- Q411325 label "Atenolol".
- Q411325 seeAlso Q816759.
- Q411325 depiction Atenolol.svg.